Vertex Pharmaceuticals missed Wall Street estimates for the first quarter of 2025, as sales of its cystic fibrosis (CF) ...

US healthcare giant Johnson & Johnson has presented data from its Phase III LUMEOS study and disclosed that the trial did not ...

US investment firm Deerfield Management has closed its latest fund with $600 million in commitments to support advances in ...

US pharma major Bristol Myers Squibb (NYSE: BMY) is set to lay off another 516 employees at its New Jersey, USA site, ...

Some $45 million has been raised in a Series B financing round by Nuevocor, an IND-stage biotech developing therapies for ...

USA-based rare disease drug developer PTC Therapeutics (Nasdaq: PTCT) on Monday announced results from the Phase II PIVOT-HD ...

UK pharma major AstraZeneca (LSE: AZN) today revealed that its Calquence (acalabrutinib) in combination with bendamustine and ...

Portugal-based Hovione and Firstgene Life Sciences, a portfolio company of the Swiss incubator Xlife Sciences (SIX: XLS), ...

Benchtop cell factory company Astraveus has entered into a strategic partnership with The Netherlands Center for the Clinical ...

The US Food and Drug Administration (FDA) accepted Novo Nordisk’s New Drug Application (NDA) submission for an ...

Priothera today announced the appointment of Jens Hasskarl, as its chief medical officer (CMO). Founded in France and ...

German biotech BioNTech (Nasdaq: BNTX) saw its shares dip 3.4% to $101.44 today, after it reported financial results for the ...